415 is a California-based venture capital firm that primarily focuses on seed-stage investments in technology companies. The firm typically invests in early-stage startups, providing both funding and strategic advice to help companies grow and succeed.
Notable portfolio companies include Catalog, a DNA data storage company, and Prellis Biologics, a bioprinting technology firm. Founded by Owen Van Natta and Grace Stanat, 415 offers value-added services to its portfolio companies, including assistance with strategy, funding, partnerships, e-commerce, operations, user acquisition, and growth. The firm's hands-on approach and expertise in tech and social media make it an attractive partner for early-stage startups.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.